Telemedicine Control Tower for the Post-Anesthesia Care Unit (PACU Telemed)

July 17, 2023 updated by: Michael Avidan, Washington University School of Medicine

A Proof-of-concept Observational Study Evaluating the Acceptability and Utility of a Telemedicine Solution for the Post Anesthesia Care Unit

A single center prospective before-and-after proof-of-concept study to evaluate a telemedicine center for the PACU.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A proof-of-concept study in perioperative telemedicine that aims to demonstrate the (i) acceptability and (ii) utility of integrating telemedicine into the PACU environment. This proof-of-concept study will be conducted in the PACU.

Study Type

Interventional

Enrollment (Actual)

560

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Saint Louis, Missouri, United States, 63110
        • Washington University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Adults (age ≥ 18) undergoing elective surgery at Barnes Jewish Hospital in St. Louis, Missouri will be enrolled

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Observation Phase
In the first three months of this proof-of-concept study, a telemedicine center for the PACU will monitor patients assigned to PACU bays. Both telemedicine center clinicians and nurses caring for patients in these PACU bays will independently record information on patient physiological derangements, treatable symptoms, situations requiring urgent medical intervention, and discharge readiness (based on the modified Aldrete scale). During this phase of the study, clinicians in the telemedicine center will not communicate with clinicians in the PACU (nurses or physicians), unless there was a patient safety event.
Experimental: Interaction Phase
In the three months following the observation phase, clinicians in the telemedicine center will interact with clinicians and patients in the two designated PACU bays using audio-visual technology. The clinicians in the telemedicine center will continue to document information on physiological derangements, treatable symptoms, situations requiring urgent medical intervention, and discharge readiness.
Decision-support software, customized for the PACU environment, Interaction between the telemedicine center and the PACU

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Time to PACU Discharge Determination From Observation to Interaction Phase
Time Frame: up to 1 day
The difference in discharge readiness time between the observation and interaction phases will be compared
up to 1 day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demonstrate the Potential Ability of a Remote Telemedicine Center for the PACU to Assist With PACU Functions.
Time Frame: up to 1 day
Percent of patients the telemedicine center participated in the hand-off process from OR to the PACU in both the observation and interaction phases. Participation by the telemedicine center was successful if the telemedicine center could both remotely join the hand-off process and collect relevant patient care information.
up to 1 day
Detection of Physiological Derangements in PACU Patients
Time Frame: approximately 1 day
The proportion of physiological derangements identified in the telemedicine center in both the observation and interaction phases
approximately 1 day
Identification of Symptoms Requiring Treatment in PACU Patients
Time Frame: approximately 1 day
Number of patients identified with symptoms requiring treatment in PACU such as pain or nausea in both the observation and interaction phases
approximately 1 day
Recognition of Situations Requiring Emergency Medical Intervention
Time Frame: approximately 1 day
The number of patients identified requiring emergency medical intervention in both the observation and interaction phases
approximately 1 day
Determination of Patient Readiness for PACU Discharge
Time Frame: approximately 1 day
Number of patients determined to be ready for PACU discharge prior to documentation by the PACU Team in both the observation and interaction phases
approximately 1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Michael S Avidan, MBBcH, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Actual)

December 6, 2021

Study Completion (Actual)

December 6, 2021

Study Registration Dates

First Submitted

March 6, 2019

First Submitted That Met QC Criteria

July 12, 2019

First Posted (Actual)

July 16, 2019

Study Record Updates

Last Update Posted (Actual)

July 19, 2023

Last Update Submitted That Met QC Criteria

July 17, 2023

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 201901180

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elective Surgery

Clinical Trials on Alertwatch - Interaction

3
Subscribe